Skip to main content
Kieren Mather, MD, Endocrinology, Indianapolis, IN, Select Specialty Hospital of INpolis

KierenMatherMDFRCPC

Endocrinology • Indianapolis, IN

Diabetes, Lipid Metabolism

Professor of Medicine

Join to view full profile

Dr. Mather is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mather's full profile

Already have an account?

Education & Training

  • University of Calgary Faculty of Medicine
    University of Calgary Faculty of MedicineClass of 1992

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1999 - 2023
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Ancestry Markers and Difference in A1c Between African-American and White in the Diabetes Prevention Program  
    Steven Kahn, William C Knowler, Kieren J Mather, Jose C Florez, The Journal of Clinical Endocrinology and Metabolism
  • Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection Versus Insulin Alone in Type 2 Diabetes  
    Kieren J Mather, Mark A Green, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

  • Beta-Cell-Targeted Tx Disappoints in New T2D Patients
    Beta-Cell-Targeted Tx Disappoints in New T2D PatientsJune 9th, 2019
  • Type 2 Diabetes Medications Don’t Prevent the Disease in People with Prediabetes, Study Suggests
    Type 2 Diabetes Medications Don’t Prevent the Disease in People with Prediabetes, Study SuggestsJune 11th, 2019
  • Long-Term Follow-up of Diabetes Prevention Program Shows Continued Reduction in Diabetes Development
    Long-Term Follow-up of Diabetes Prevention Program Shows Continued Reduction in Diabetes DevelopmentJune 16th, 2014
  • Join now to see all

Grant Support

  • Preservation Of Beta Cell Function In Prediabetes/Early Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Preservation Of Beta Cell Function In Prediabetes Early Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2011
  • Modulation Of Human Myocardial Metabolism By GLP-1National Heart, Lung, And Blood Institute2010–2011
  • Repaglinide As A Viable Alternative To Pre-Meal Insulin In Cystic Fibrosis RENational Center For Research Resources2007–2008
  • Myocardial Substrate Selection And Switching In Lean And Obese HumansNational Center For Research Resources2007–2008
  • Dual Actions Of Insulin In The Regulation Of Endothelin Activity In Vivo In HNational Center For Research Resources2006–2008
  • Treating The Endothelium To Restore Insulin SensitivityNational Center For Research Resources2005–2008
  • Mechanism Of Hemodynamically Induced Glucose UptakeNational Center For Research Resources2004–2008
  • PET Approach To Measuring Human Myocardial MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
  • The Effects Of Olmesartan Medoxomil, Losartan Potassium, And Atenolol On InsuNational Center For Research Resources2005–2006
  • Role Of Hemodynamics In In Vivo Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2003

Hospital Affiliations

Dr. Kieren Mather, Dr. Kieren Mather, MD, Dr. K Mather